Blood levels of histamine, IL-1β, and TNF-α in patients with mild to moderate alzheimer disease
Abstract
In this study, we have evaluated the levels of blood histamine, serum interleukin-1 beta (IL-1 beta), and plasma tumor necrosis factor-alpha (TNF-alpha) in 20 patients with mild to moderate Alzheimer disease (AD; 13 early onset and 7 late-onset AD subjects) and in 20 age-matched control subjects (C). AD patients showed higher concentrations of histamine (AD = 452.9 +/- 237.9 pmol/mL; C = 275.3 +/- 151.5 pmol/mL; p < 0.05) and IL-1 beta (AD = 211.2 +/- 31.1 pg/mL; C = 183.4 +/- 24.4 pg/mL; p < 0.01), and lower values of TNF-alpha (AD = 3.59 +/- 2.02 pg/mL; C = 9.47 +/- 2.64 pg/mL; p < 0.001) than elderly controls. Increased levels of histamine and decreased levels of TNF-alpha were observed in both early onset AD (EOAD) and late-onset AD (LOAD) patients, but only EOAD subjects had elevated serum IL-1 beta values compared with age-matched controls. Age negatively correlated with histamine (r = -0.57; p < 0.05) and positively with IL-1 beta levels (r = 0.48; p < 0.05) in healthy subjects, but not in AD, whereas a positive correlation between TNF-alpha scores and age was only found in AD patients (r = 0.46; p < 0.05). Furthermore, histamine and TNF-alpha values correlated negatively in AD (r = -0.50, p < 0.05). In addition, cognitive impairment increased in patients with lower TNF-alpha and higher histamine and IL-1 beta levels, as indicated by the correlations between mental performance scores and histamine (r = -0.37, ns), IL-1 beta (r = -0.33, ns) and TNF-alpha levels (r = 0.42, p < 0.05). Finally, histamine concentrations decreased as depression scores increased in AD (r = -0.63, p < 0.01). These data suggest a dysfunction in cytokine and histamine regulation in AD, probably indicating changes associated with inflammatory processes.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Systemic inflammation is involved in the pathophysiology of neuropsychiatric diseases such as depression and schizophrenia as well as age-related cognitive decline.
“In addition, there is growing experimental and clinical evidence implicating systemic inflammation to be involved in the pathophysiology of neuropsychiatric diseases such as depression and schizophrenia as well as age-related cognitive decline [7], [8], [9], [10], [11], [12], [13], [14].”
From Dose-dependent effects of endotoxin on neurobehavioral functions in humans (2011) · cites this paper as [7]
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282 · see citing works
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817 · see citing works
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915 · see citing works
Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.
Griffin, W. S., Stanley, L. C., Ling, C., White, L., MacLeod, V, Perrot, L. J., White, C. L., & Araoz, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7611 · Cited by 1,777 · see citing works
MULTI-INFARCT DEMENTIA A CAUSE OF MENTAL DETERIORATION IN THE ELDERLY
HACHINSKI, V (1974) · The Lancet · doi:10.1016/s0140-6736(74)91496-2 · Cited by 1,093 · see citing works
Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells.
Goldgaber, D., Harris, H. W., Hla, T., Maciag, T., DONNELLY, R. J., Jacobsen, J. S., Vitek, M. P., & Gajdusek, D. C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7606 · Cited by 591 · see citing works
Elevated circulating tumor necrosis factor levels in Alzheimer's disease
Fillit, H. M., Ding, W., Buée, L., Kalman, J., Altstiel, L. D., LAWLOR, B. A., & Wolf-Klein, G. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90490-k · Cited by 513 · see citing works
Microglia in degenerative neurological disease
McGeer, P. L., Kawamata, T., Walker, D. G., Akiyama, H., Tooyama, I., & McGeer, E. G. (1993) · Glia · doi:10.1002/glia.440070114 · Cited by 500 · see citing works
Immune System Response in Alzheimer's Disease
McGeer, P. L., Akiyama, H., Itagaki, S., & McGeer, E. G. (1989) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100029863 · Cited by 460 · see citing works
Yamatodani, A., Fukuda, H., Wada, H., Iwaeda, T., & Watanabe, T. (1985) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(00)82012-5 · Cited by 396 · see citing works
Strauss, S., Bauer, J., Ganter, U., Jonas, U., Berger, T., & Volk, B. (1992) · PubMed · Cited by 331 · see citing works
Forloni, G., Demicheli, F., Giorgi, S., Bendotti, C., & Angeretti, N. (1992) · Molecular Brain Research · doi:10.1016/0169-328x(92)90202-m · Cited by 255 · see citing works
Wood, J. A., Wood, P. L., Ryan, R., Graff-Radford, N. R., Pilapil, C., Robitaille, Y., & Quirion, R. (1993) · Brain Research · doi:10.1016/0006-8993(93)91327-o · Cited by 244 · see citing works
Interleukin 1 releases histamine from human basophils and mast cells in vitro.
Subramanian, N., & Bray, M. A. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.1.271 · Cited by 183 · see citing works
Brain interleukin-1 beta in Alzheimer's disease and vascular dementia.
Cacabelos, R., Alvarez, X. A., Fernández‐Novoa, L., Franco, A., Mangues, R., Pellicer, À., & Nishimura, T. (1994) · PubMed · Cited by 182 · see citing works
Self-citationA new scale for the assessment of depressed mood in demented patients
Sunderland, T., Alterman, I., Yount, D., Hill, J., Tariot, P. N., NEWHOUSE, P. A., Mueller, E. A., Mellow, A. M., & Rm, C. (1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.8.955 · Cited by 173 · see citing works
Involvement of cytokines in acute neurodegeneration in the CNS
Rothwell, N. J., & Relton, J. K. (1993) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(05)80152-6 · Cited by 170 · see citing works
Histamine neurons in human hypothalamus: Anatomy in normal and alzheimer diseased brains
Alraksinen, M. S., Paetau, A. E., Paljärvi, L., Reinikainen, K. J., Rlekkinen, P., Suomalainen, R., & Panula, P. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90070-5 · Cited by 163 · see citing works
Vannier, E. G., Miller, L. C., & Dinarello, C. A. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.174.1.281 · Cited by 161 · see citing works
Cacabelos, R., Barquero, M. S., Garcia, P. E., Alvarez, X. A., & de Seijas, E. V. (1991) · PubMed · Cited by 148 · see citing works
Self-citationRada, P. V., Mark, G. P., Vitek, M. P., Mangano, R. M., Blume, A. J., Beer, B., & Hoebel, B. G. (1991) · Brain Research · doi:10.1016/0006-8993(91)91330-4 · Cited by 126 · see citing works
Tumor necrosis factors — the molecules and their emerging role in medicine
Blankenstein, T. J. F. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90051-8 · Cited by 117 · see citing works
Gray, C. W., & Patel, A. J. (1993) · Molecular Brain Research · doi:10.1016/0169-328x(93)90037-p · Cited by 113 · see citing works
Cytokines and the hypothalamic-pituitary-adrenal axis
Hermus, A. R. M. M., & Sweep, F. C. G. J. (1990) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(90)90434-m · Cited by 106 · see citing works
Correlation of cytokine secretion by mononuclear cells of Alzheimer patients and their disease stage
Huberman, M., Shalit, F., Roth‐Deri, I., Gutman, B., Brodie, C., Kott, E., & Sredni, B. (1994) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)90108-2 · Cited by 105 · see citing works
Tazi, A., Dantzer, R., Crestani, F., & Moal, M. L. (1988) · Brain Research · doi:10.1016/0006-8993(88)90868-2 · Cited by 102 · see citing works
α2-macroglobulin expression in neuritic-type plaques in patients with Alzheimer's disease
Gool, D. V., Strooper, B. D., LEUVEN, F. V., Triau, E., & Dom, R. (1993) · Neurobiology of Aging · doi:10.1016/0197-4580(93)90006-w · Cited by 101 · see citing works
Cytokines in Alzheimer's disease
Altstiel, L. D., & Sperber, K. E. (1991) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(91)90023-t · Cited by 99 · see citing works
Rozemüller, A. J. M., Stam, F. C., & Eikelenboom, P. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90759-3 · Cited by 98 · see citing works
α1-Antichymotrypsin and IL-1β are not increased in CSF or serum in Alzheimer's disease
Pirttilä, T., Mehta, P. D., Frey, H., & Wı́sniewski, H. M. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90026-4 · Cited by 94 · see citing works
Mazurkiewicz-Kwilecki, I. M., & Nsonwah, S. (1989) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y89-013 · Cited by 94 · see citing works
Brain histamine in Alzheimer's disease.
Cacabelos, R., Yamatodani, A., Niigawa, H., Hariguchi, S., Tada, K., Nishimura, T., Wada, H., Brandeis, L., & Pearson, J. (1989) · PubMed · Cited by 83 · see citing works
Self-citationNakamura, S., Takemura, M., Ohnishi, K., Suenaga, T., Nishimura, M., Akiguchi, I., Kimura, J., & Kimura, T. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90019-h · Cited by 71 · see citing works
Serum tumor necrosis factor (TNF) in Alzheimer's disease and multi-infarct dementia.
Cacabelos, R., Alvarez, X. A., Franco-Maside, A., Fernández‐Novoa, L., & Caamaño, J. C. (1994) · PubMed · Cited by 69 · see citing works
Self-citationMassey, W. A., Randall, T. C., Kagey‐Sobotka, A., Warner, J. A., MacDonald, S. M., Gillis, S. A., ALLISON, A. C., & Lichtenstein, L. M. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.6.1875 · Cited by 56 · see citing works
Reisberg, ., Ferris, S. H., & de Leon, M. J. (1985) · Advances in applied neurological sciences · doi:10.1007/978-3-642-70644-8_2 · Cited by 54 · see citing works
Elevated interleukin-6 secretion levels by mononuclear cells of Alzheimer's patients
Shalit, F., Sredni, B., Stern, L., Kott, E., & Huberman, M. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90003-5 · Cited by 54 · see citing works
Neuroimmunology of Alzheimer's disease: A conference report
Dickson, D. W., & Rogers, J. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90104-6 · Cited by 44 · see citing works
Cacabelos, R., Alvarez, X. A., Franco-Maside, A., Fernández‐Novoa, L., & Caamaño, J. C. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb23076.x · Cited by 41 · see citing works
Self-citationInterleukin-1 in Alzheimer's disease and multi-infarct dementia: neuropsychological correlations.
Cacabelos, R., Franco-Maside, A., & Alvarez, X. A. (1991) · PubMed · Cited by 41 · see citing works
Self-citationThe role of the acute-phase protein α1-antichymotrypsin in brain dysfunction and injury
Abraham, C. R. (1992) · Research in Immunology · doi:10.1016/0923-2494(92)80047-o · Cited by 40 · see citing works
Martı́nez, M., Frank, A., & Hernánz, Á. (1993) · Journal of Neuroimmunology · doi:10.1016/0165-5728(93)90197-7 · Cited by 37 · see citing works
Blume, A. J., & Vitek, M. P. (1989) · Neurobiology of Aging · doi:10.1016/0197-4580(89)90077-8 · Cited by 36 · see citing works
Holliday, J., & Gruol, D. L. (1993) · Brain Research · doi:10.1016/0006-8993(93)90111-y · Cited by 35 · see citing works
Cacabelos, R., Nordberg, A., & Caamaño, J. C. (1994) · Drugs of today · doi:10.1358/dot.1994.30.4.287372 · Cited by 30 · see citing works
Self-citationCDP-choline-induced blood histamine changes in Alzheimer's disease.
Fernández‐Novoa, L., Alvarez, X. A., Franco-Maside, A., Caamaño, J. C., & Cacabelos, R. (1994) · PubMed · Cited by 23 · see citing works
Self-citationSerum histamine in Alzheimer's disease and multi-infarct dementia.
Cacabelos, R., Fernández‐Novoa, L., Jm, P.-T., Franco-Maside, A., & Alvarez, X. A. (1992) · PubMed · Cited by 21 · see citing works
Self-citationEffects of neurotoxic lesions in histaminergic neurons on brain tumor necrosis factor levels
Alvarez, X. A., Franco, A., Fernández‐Novoa, L., & Cacabelos, R. (1994) · Inflammation Research · doi:10.1007/bf02007772 · Cited by 20 · see citing works
Self-citationIncreased proteolytic activity in lymphocytes from patients with early onset Alzheimer's disease
Karlsson, J., Blennow, K., Janson, I., Blomgren, K., Karlsson, I., Regland, B., Wallin, A., & Gottfries, C. G. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)02004-7 · Cited by 20 · see citing works
Contrasting Effects of Specific Lymphokines on the Survival of Hippocampal Neurons in Culture
Araujo, D. M. (1992) · Advances in behavioral biology · doi:10.1007/978-1-4615-3432-7_9 · Cited by 19 · see citing works
Effect of Histamine on Tumor Necrosis Factor Production by Human Monocytes
Hotermans, G., Bury, T., & Radermecker, M. F. (2009) · International Archives of Allergy and Applied Immunology · doi:10.1159/000235442 · Cited by 18 · see citing works
Interleukin-1β inhibits acetylcholine synthesis in the pituitary corticotropic cell line AtT20
Carmeliet, P., Damme, J. V., & Denef, C. (1989) · Brain Research · doi:10.1016/0006-8993(89)90106-6 · Cited by 17 · see citing works
Effects of histamine andα-fluoromethylhistidine on brain tumor necrosis factor levels in rats
Fernández‐Novoa, L., Franco-Maside, A., Alvarez, X. A., & Cacabelos, R. (1995) · Inflammation Research · doi:10.1007/bf01630488 · Cited by 15 · see citing works
Self-citationSawada, M., Hara, N., & Maéno, T. (1992) · Cellular and Molecular Neurobiology · doi:10.1007/bf00711544 · Cited by 13 · see citing works
Heinonen, O., Syrjänen, S., Soininen, H., Talasniemi, S., Kaski, M., Mäntyjärvi, R. A., Syrjänen, K. J., & Riekkinen, P. J. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90349-p · Cited by 9 · see citing works
[Neuroimmunology of Alzheimer's disease].
Novák, M. (1997) · PubMed · Cited by 9 · see citing works
Alvarez, X. A., Franco, A., Fernández‐Novoa, L., & Cacabelos, R. (1993) · European Neuropsychopharmacology · doi:10.1016/0924-977x(93)90212-5 · Cited by 1 · see citing works
Self-citationAlvarez, X. A., Franco, A., Rettori, M., Kamoun, A., Polo, E., & Cacabelos, R. (1993) · European Neuropsychopharmacology · doi:10.1016/0924-977x(93)90225-b · Cited by 1 · see citing works
Self-citation
Flagged first, then by citations
1 of the 59 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
A Meta-Analysis of Cytokines in Alzheimer's Disease
Swardfager, W., Lanctôt, K., Rothenburg, L., Wong, A., Cappell, J., & Herrmann, N. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.012 · Cited by 1,108 · see citing works
Proinflammatory Cytokines, Aging, and Age-Related Diseases
Michaud, M., Balardy, L., Moulis, G., Gaudin, C., Peyrot, C., Vellas, B., Cesari, M., & Nourhashemi, F. (2013) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.05.009 · Cited by 1,094 · see citing works
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins
Ray, S., Britschgi, M., Herbert, C., Takeda-Uchimura, Y., Boxer, A., Blennow, K., Friedman, L. F., Galasko, D. R., Jutel, M., Karydas, A., et al. (2007) · Nature Medicine · doi:10.1038/nm1653 · Cited by 1,048 · see citing works
Inflammatory mediators in the elderly
Krabbe, K. S., Pedersen, M., & Bruunsgaard, H. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.01.009 · Cited by 928 · see citing works
Early inflammation and dementia: A 25‐year follow‐up of the Honolulu‐Asia aging study
Schmidt, R., Schmidt, H., Curb, J. D., Masaki, K., White, L. R., & Launer, L. J. (2002) · Annals of Neurology · doi:10.1002/ana.10265 · Cited by 710 · see citing works
Inflammatory markers and cognition in well-functioning African-American and white elders
Yaffe, K., Lindquist, K., Penninx, B. W., Simonsick, E. M., Pahor, M., Kritchevsky, S., Launer, L., Kuller, L., Rubin, S., & Harris, T. (2003) · Neurology · doi:10.1212/01.wnl.0000073620.42047.d7 · Cited by 706 · see citing works
Cytokines and cognition–the case for a head-to-toe inflammatory paradigm.
Wilson, C. J., Finch, C. E., & Cohen, H. J. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50619.x · Cited by 637 · see citing works
Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis
Westfall, S., Lomis, N., Kahouli, I., Dia, S. Y., Singh, S. P., & Prakash, S. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2550-9 · Cited by 551 · see citing works
Brosseron, F., Krauthausen, M., Kummer, M., & Heneka, M. T. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8657-1 · Cited by 447 · see citing works
Licastro, F., Pedrini, S., Caputo, L., Annoni, G., Davis, L. J., Ferri, C., Casadei, V. M., & Grimaldi, L. M. E. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00226-x · Cited by 400 · see citing works
Review: Systemic inflammation and<scp>A</scp>lzheimer's disease
Holmes, C. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2012.01307.x · Cited by 356 · see citing works
Neuroinflammation: Implications for the Pathogenesis and Molecular Diagnosis of Alzheimer's Disease
Rojo, L. E., Fernández, J. A., Maccioni, A. A., Jimenez, J. M., & Maccioni, R. B. (2008) · Archives of Medical Research · doi:10.1016/j.arcmed.2007.10.001 · Cited by 351 · see citing works
Anisman, H., Merali, Z., & Hayley, S. P. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.01.004 · Cited by 334 · see citing works
Neuroprotective effects of physical activity on the brain: a closer look at trophic factor signaling
Phillips, C., Baktir, M. A., Srivatsan, M., & Salehi, A. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00170 · Cited by 330 · see citing works
Metabolome in progression to Alzheimer's disease
Orešič, M., Hyötyläinen, T., Herukka, S.-K., Sysi‐Aho, M., Mattila, I. M., Seppänan-Laakso, T., Julkunen, V., Gopalacharyulu, P. V., Hallikainen, M., Koikkalainen, J. R., et al. (2011) · Translational Psychiatry · doi:10.1038/tp.2011.55 · Cited by 280 · see citing works
Serum TNF-alpha levels are increased and correlate negatively with free IGF-I in Alzheimer disease
Álvarez, A., Cacabelos, R., Sanpedro, C., García-Fantini, M., & Aleixandre, M. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.02.012 · Cited by 278 · see citing works
Self-citationDose-dependent effects of endotoxin on neurobehavioral functions in humans
Grigoleit, J.-S., Kullmann, J. S., Wolf, O. T., Hammes, F., Wegner, A., Jablonowski, S., Engler, H., Gizewski, E., Oberbeck, R., & Schedlowski, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028330 · Cited by 241 · see citing works
Dursun, E., Gezen-Ak, D., Hanağası, H., Bilgiç, B., Lohmann, E., Ertan, S., Atasoy, İ. L., Alaylıoğlu, M., Araz, Ö. S., Önal, B., et al. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.04.014 · Cited by 237 · see citing works
Cytokines and C-Reactive Protein Production in Hip-Fracture-Operated Elderly Patients
Beloosesky, Y., Hendel, D., Weiss, A. T., Hershkovitz, A., Grinblat, J., Pirotsky, A., & Barak, V. (2007) · The Journals of Gerontology Series A · doi:10.1093/gerona/62.4.420 · Cited by 237 · see citing works
Peripheral inflammatory biomarkers in Alzheimer’s disease: a brief review
Park, J., Han, S.-H., & Mook‐Jung, I. (2020) · BMB Reports · doi:10.5483/bmbrep.2020.53.1.309 · Cited by 200 · see citing works
Peripheral inflammation in prodromal Alzheimer’s and Lewy body dementias
King, E., O'Brien, J. T., Donaghy, P. C., Morris, C. M., Barnett, N. A., Olsen, K., Martin-Ruiz, C. M., Taylor, J., & Thomas, A. J. (2017) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-317134 · Cited by 187 · see citing works
Low-dose endotoxemia and human neuropsychological functions
Krabbe, K. S., Reichenberg, A., Yirmiya, R., Smed, A., Pedersen, B. K., & Bruunsgaard, H. (2005) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2005.04.010 · Cited by 189 · see citing works
Gezen-Ak, D., Dursun, E., Hanağası, H., Bilgiç, B., Lohman, E., Araz, Ö. S., Atasoy, İ. L., Alaylıoğlu, M., Önal, B., Gürvit, H., et al. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-130497 · Cited by 188 · see citing works
Risk Factors of Aspiration Pneumonia in Alzheimer’s Disease Patients
Wada, H., Nakajoh, K., Satoh‐Nakagawa, T., Suzuki, T., Ohrui, T., Arai, H., & Sasaki, H. (2001) · Gerontology · doi:10.1159/000052811 · Cited by 183 · see citing works
Interleukin-6 Covaries Inversely With Cognitive Performance Among Middle-Aged Community Volunteers
Marsland, A. L., Petersen, K. L., Sathanoori, R., Muldoon, M. F., Neumann, S. A., Ryan, C. M., Flory, J. D., & Manuck, S. B. (2006) · Psychosomatic Medicine · doi:10.1097/01.psy.0000238451.22174.92 · Cited by 179 · see citing works
Serum BDNF, TNF-α and IL-1β levels in dementia patients
Yasutake, C., Kuroda, K., Yanagawa, T., Okamura, T., & Yoneda, H. (2006) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-006-0652-8 · Cited by 177 · see citing works
Biochemical markers related to Alzheimer’s dementia in serum and cerebrospinal fluid
Teunissen, C. E., de Vente, J., Steinbusch, H. W. M., & Bruijn, C. D. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00328-1 · Cited by 167 · see citing works
Peripheral Inflammatory Cytokines as Biomarkers in Alzheimer’s Disease and Mild Cognitive Impairment
Guerreiro, R. J., Santana, I. J., Brás, J., Santiago, B., Paiva, A. A., & Oliveira, C. R. (2007) · Neurodegenerative Diseases · doi:10.1159/000107700 · Cited by 150 · see citing works
Peripheral Cytokines and Chemokines in Alzheimer’s Disease
Lee, K. S., Chung, J. H., Choi, T.-K., Suh, S. Y., Oh, B. H., & Hong, C. H. (2009) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000245156 · Cited by 140 · see citing works
Gong, T., Chen, Q., Mao, H., Zhang, Y., Ren, H., Xu, M., Chen, H., & Yang, D. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.925435 · Cited by 138 · see citing works
Inflammatory Markers and Their Association with Post Stroke Cognitive Decline
Narasimhalu, K., Lee, J. H., Leong, Y.-L., Ma, L., Silva, D. A. D., Wong, M.-C., Chang, H., & Chen, C. (2013) · International Journal of Stroke · doi:10.1111/ijs.12001 · Cited by 132 · see citing works
Mitochondrial damage in Alzheimer's disease varies with apolipoprotein E genotype
Gibson, G. E., Haroutunian, V. H., Zhang, H., Park, L. C. H., Shi, Q., LESSER, M. L., Mohs, R. C., Sheu, R., & Blass, J. P. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200009)48:3 · Cited by 184 · see citing works
Histamine induces microglia activation and dopaminergic neuronal toxicity via H1 receptor activation
Rocha, S. M., Saraiva, T., Cristóvão, A. C., Ferreira, R., Santos, T., Esteves, M., Saraiva, C., Je, G., Cortes, L., Valero, J., et al. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0600-0 · Cited by 117 · see citing works
Maes, M. H. J., Devos, N., Wauters, A., Demedts, P., Maurits, V., Neels, H. M., Bosmans, E., Altamura, C. A., Lin, A., Song, C., et al. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(99)00016-3 · Cited by 110 · see citing works
Systemic and Acquired Immune Responses in Alzheimer's Disease
Britschgi, M., & Wyss‐Coray, T. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(07)82011-3 · Cited by 105 · see citing works
Neuronal histamine and cognitive symptoms in Alzheimer's disease
Zlomuzica, A., Dere, D., Binder, S., Silva, M. A. D. S., Huston, J. P., & Dere, E. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.05.007 · Cited by 99 · see citing works
Comorbidity Factors and Brain Mechanisms Linking Chronic Stress and Systemic Illness
Đurić, V., Clayton, S., Leong, M. L., & Yuan, L. (2016) · Neural Plasticity · doi:10.1155/2016/5460732 · Cited by 104 · see citing works
Histamine function in brain disorders
Fernández‐Novoa, L. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00215-7 · Cited by 93 · see citing works
Self-citationDecreased IL-8 levels in CSF and serum of AD patients and negative correlation of MMSE and IL-1β
Hesse, R., Wahler, A., Gummert, P., Kirschmer, S., Otto, M., Tumani, H., Lewerenz, J., Schnack, C., & Arnim, C. A. F. V. (2016) · BMC Neurology · doi:10.1186/s12883-016-0707-z · Cited by 85 · see citing works
Peripheral Chemo-Cytokine Profiles in Alzheimers and Parkinsons Diseases
Reale, M., Greig, N., & Kamal, M. (2009) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955709789055199 · Cited by 82 · see citing works
Association of Midlife Inflammatory Markers With Cognitive Performance at 10-Year Follow-up
Kipinoinen, T., Toppala, S., Rinne, J. O., Viitanen, M. H., Jula, A., & Ekblad, L. L. (2022) · Neurology · doi:10.1212/wnl.0000000000201116 · Cited by 81 · see citing works
Raised Serum Proinflammatory Cytokines in Alzheimer’s Disease with Depression
Khemka, V. K. (2014) · Aging and Disease · doi:10.14336/ad.2014.0500170 · Cited by 74 · see citing works
Engelborghs, S., Brabander, M. D., Crée, J. D., D’Hooge, R., Geerts, H., Verhaegen, H., & Deyn, P. P. D. (1999) · Neurochemistry International · doi:10.1016/s0197-0186(99)00031-5 · Cited by 69 · see citing works
Gut Microbiota Regulation and Their Implication in the Development of Neurodegenerative Disease
Sun, P., Su, L., Zhu, H., Li, X., Guo, Y., Du, X., Zhang, L., & Qin, C. (2021) · Microorganisms · doi:10.3390/microorganisms9112281 · Cited by 66 · see citing works
Khan, T. K., & Alkon, D. L. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605411103 · Cited by 64 · see citing works
New Anti-inflammatory Treatment Strategy in Alzheimer’s Disease
Sugaya, K., Uz, T., Kumar, V., & Manev, H. (2000) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.82.85 · Cited by 64 · see citing works
Serum IL‐8 is a marker of white‐matter hyperintensities in patients with Alzheimer's disease
Zhu, Y., Chai, Y. L., Hilal, S., Ikram, M. K., Venketasubramanian, N., Wong, B., Chen, C., & Lai, M. K. P. (2017) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2017.01.001 · Cited by 61 · see citing works
Alvarez, X. A., Lombardi, V., Fernández‐Novoa, L., Garcı́a, M., Sampedro, C., Cagiao, A. M. M., Cacabelos, R., & Windisch, M. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6781-6_30 · Cited by 60 · see citing works
Self-citationPeripheral Inflammatory Response in Alzheimer's Disease and Multiinfarct Dementia
Luigi, A. D., Pizzimenti, S., Quadri, P., Lucca, U., Tettamanti, M., Fragiacomo, C., & Simoni, M. G. D. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0556 · Cited by 59 · see citing works
Licastro, F., Chiappelli, M., Ruscica, M., Carnelli, V., & Corsi, M. M. (2005) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200501800117 · Cited by 59 · see citing works
Targeting gut microbiota to alleviate neuroinflammation in Alzheimer’s disease
Nguyen, V. T. T., & Endres, K. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114418 · Cited by 52 · see citing works
Gambi, F., Reale, M., Iarlori, C., Salone, A., Toma, L., Paladini, C., Luca, G. D., Feliciani, C., Salvatore, M., Salerno, R. M., et al. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000125683.74595.2f · Cited by 53 · see citing works
Furney, S. J., Kronenberg‐Versteeg, D., Simmons, A., Güntert, A., Dobson, R., Proitsi, P., Wahlund, L., Kłoszewska, I., Mecocci, P., Soininen, H. S., et al. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-0044 · Cited by 54 · see citing works
Chen, A., Oakley, A. E., Monteiro, M. P. A. O., Tuomela, K., Allan, L. M., Mukaetova‐Ladinska, E. B., O'Brien, J. T., & Kalaria, R. N. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.10.021 · Cited by 52 · see citing works
Histamine and Immune Biomarkers in CNS Disorders
Cacabelos, R., Torrellas, C., Fernández‐Novoa, L., & Lopez-Munoz, F. J. (2016) · Mediators of Inflammation · doi:10.1155/2016/1924603 · Cited by 52 · see citing works
Self-citationBrain Protection in Schizophrenia, Mood and Cognitive Disorders
Ritsner, M. S. (2010) · Springer eBooks · doi:10.1007/978-90-481-8553-5 · Cited by 52 · see citing works
The Association between TNF-alpha, IL-1 alpha and IL-10 with Alzheimer's Disease
Čuljak, M., Perković, M. N., Uzun, S., Štrac, D. Š., Erjavec, G. N., Leko, M. B., Šimić, G., Tudor, L., Konjevod, M., Kozumplik, O., et al. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666201130092427 · Cited by 51 · see citing works
Cerebrospinal fluid and blood biomarkers in Alzheimer’s disease
Humpel, C. (2011) · World Journal of Psychiatry · doi:10.5498/wjp.v1.i1.8 · Cited by 51 · see citing works
Plasma Markers of Inflammation Linked to Clinical Progression and Decline During Preclinical AD
Gross, A. L., Walker, K. A., Moghekar, A. R., Pettigrew, C., Soldan, A., Albert, M. S., & Walston, J. D. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00229 · Cited by 49 · see citing works
Smith, E. R., Nilforooshan, R., Weaving, G., & Tabet, N. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-101872 · Cited by 47 · see citing works
Schmitz, M., Hermann, P., Oikonomou, P., Stoeck, K., Ebert, E., Poliakova, T., Schmidt, C., Llorens, F., Zafar, S., & Zerr, I. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.05.013 · Cited by 47 · see citing works
Attia, H., Albuhayri, S., Alaraidh, S., Alotaibi, A., Yacoub, H. I., Mohamad, R. A., & Alamin, M. A. (2020) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22519 · Cited by 47 · see citing works
Peripheral inflammation in neurodegeneration
Träger, U., & Tabrizi, S. J. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1026-0 · Cited by 46 · see citing works
Katsipis, G., Tzekaki, E. E., Tsolaki, M., & Pantazaki, Α. A. (2021) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2021.577744 · Cited by 47 · see citing works
Wilson, C. J., Cohen, H. J., & Pieper, C. F. (2003) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2003.51454.x · Cited by 45 · see citing works
Role of Pro-Inflammatory Cytokines and Vitamin D in Probable Alzheimer's Disease with Depression
Banerjee, A., Khemka, V. K., Roy, D., Dhar, A., Roy, T. K. S., Biswas, A., Mukhopadhyay, B. K., & Chakrabarti, S. (2017) · Aging and Disease · doi:10.14336/ad.2016.1017 · Cited by 44 · see citing works
Yang, S., Pascual-Guiral, S., Landete, R. P., Giménez‐Llort, L., Baltrons, M. A., Arancio, O., Palacio, J. R., Clos, M. V., Yuste, V. J., & Bayascas, J. R. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00435 · Cited by 44 · see citing works
Rejdak, K., Sienkiewicz‐Jarosz, H., Bieńkowski, P., & Álvarez, A. (2023) · Medicinal Research Reviews · doi:10.1002/med.21960 · Cited by 43 · see citing works
Enhanced susceptibility of triple transgenic Alzheimer’s disease (3xTg-AD) mice to acute infection
Montacute, R., Foley, K., Forman, R., Else, K. J., Cruickshank, S. M., & Allan, S. M. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0826-5 · Cited by 43 · see citing works
Piperlongumine Improves Lipopolysaccharide-Induced Amyloidogenesis by Suppressing NF-KappaB Pathway
Gu, S. M., Lee, H. P., Ham, Y. W., Son, D. J., Kim, H. Y., Oh, K. W., Han, S., Yun, J., & Hong, J. T. (2018) · NeuroMolecular Medicine · doi:10.1007/s12017-018-8495-9 · Cited by 43 · see citing works
Histamine Stimulates Neurogenesis in the Rodent Subventricular Zone
Bernardino, L. I., Eiriz, M. F., Santos, T., Xapelli, S., Grade, S., Rosa, A. I., Cortes, L., Ferreira, R., Bragança, J., Agasse, F., et al. (2012) · Stem Cells · doi:10.1002/stem.1042 · Cited by 43 · see citing works
Pharmacogenomics for the treatment of dementia
Cacabelos, R. (2002) · Annals of Medicine · doi:10.1080/078538902320772115 · Cited by 40 · see citing works
Self-citationLicastro, F. (2003) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(03)00034-4 · Cited by 38 · see citing works
Potential Blood Biomarker for Disease Severity in the Taiwanese Population With Alzheimer’s Disease
Huang, C.-W., Wang, S.-J., Wu, S.-J., Yang, C.-C., Huang, M.-W., Lin, C., & Cheng, I. H.-J. (2012) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317512467674 · Cited by 37 · see citing works
Systemic and Central Immunity in Alzheimer's Disease: Therapeutic Implications
Butchart, J., & Holmes, C. (2011) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2011.00245.x · Cited by 35 · see citing works
Park, J. K., Lee, K., Kim, J. Y., & Kim, H. (2021) · Psychiatry Investigation · doi:10.30773/pi.2020.0205 · Cited by 28 · see citing works
Decreased mRNA expression of CCL5 [RANTES] in Alzheimer's disease blood samples
Kester, M. I., van der Flier, W. M., Visser, A., Blankenstein, M. A., Scheltens, P., & Oudejans, C. B. M. (2011) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2011.731 · Cited by 34 · see citing works
Uceda, S., Echeverry‐Alzate, V., Reiriz, M., Miguel, E. M., Pérez-Curiel, A., Gómez-Senent, S., & Beltrán-Velasco, A. I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713294 · Cited by 35 · see citing works
Packer, N. H., Pervaiz, N., & Hoffman‐Goetz, L. (2010) · PubMed · Cited by 31 · see citing works
Pentraxins and Alzheimer's disease: At the interface between biomarkers and pharmacological targets
Osera, C., Pascale, A., Amadio, M., Venturini, L., Govoni, S. M., & Ricevuti, G. (2011) · Ageing Research Reviews · doi:10.1016/j.arr.2011.12.004 · Cited by 30 · see citing works
Pan, Y., Omori, K., Ali, I., Tachikawa, M., Terasaki, T., Brouwer, K. L. R., & Nicolazzo, J. A. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00500 · Cited by 30 · see citing works
Alvarez, X. A., Lombardi, V., Corzo, L., Pérez, P., Pichel, V., Laredo, M., Hernández, A. Y., Freixeiro, F., Sampedro, C., Lorenzo, R. D., et al. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6781-6_33 · Cited by 30 · see citing works
Self-citationInflammatory and Pro-resolving Mediators in Frontotemporal Dementia and Alzheimer’s Disease
Fraga, V. G., Magalhaes, C. A., Loures, C. D. M. G., de Souza, L. C., Guimarães, H. C., Zauli, D. A. G., Ferriani, M. D. G. C., Ferreira, C. N., Caramelli, P., Sousa, L. P., et al. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.09.008 · Cited by 28 · see citing works
Determination of histamine in the whole blood of colon cancer patients
Previati, M., Raspadori, A., Bertolaso, L., Parmeggiani, A., Bindini, D., Vitali, C., Lanzoni, I., Corbacella, E., Saviano, M., Fagioli, F., et al. (2002) · Journal of Chromatography B · doi:10.1016/s1570-0232(02)00541-x · Cited by 28 · see citing works
U1 snRNP Alteration and Neuronal Cell Cycle Reentry in Alzheimer Disease
Bai, B. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00075 · Cited by 27 · see citing works
Hydroxychavicol inhibits immune responses to mitigate cognitive dysfunction in rats
Pandey, A., & Bani, S. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.05.031 · Cited by 27 · see citing works
A unifying hypothesis of Alzheimer's disease. II. Pathophysiological processes
Heininger, K. (1999) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/(sici)1099-1077(199912)14:8 · Cited by 26 · see citing works
Anuradha, U., Kumar, A., & Singh, R. K. (2021) · Neurological Sciences · doi:10.1007/s10072-021-05343-7 · Cited by 24 · see citing works
Aging Microglia: Relevance to Cognition and Neural Plasticity
Kohman, R. A. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-071-7_11 · Cited by 24 · see citing works
Kaushik, A. C., Kumar, A., Dwivedi, V. D., Bharadwaj, S., Kumar, S., Bharti, K., Kumar, P., Chaudhary, R. K., & Mishra, S. K. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0546-y · Cited by 21 · see citing works
Hirai, A., Yamazaki, R., Kobayashi, A., Kimura, T., Nomiyama, K., Shimma, S., Nakayama, S. M. M., Ishizuka, M., & Ikenaka, Y. (2022) · Toxics · doi:10.3390/toxics10110696 · Cited by 21 · see citing works
Privou, C., Li, J.-S., Hasenöhrl, R., & Huston, J. (1999) · Neurobiology of Learning and Memory · doi:10.1006/nlme.1998.3885 · Cited by 19 · see citing works
Wei, S., Ma, X., Chen, Y., Wang, J., Hu, L., Liu, Z., Mo, L.-D., Zhou, N., Chen, W.-R., Zhu, H., et al. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04579-6 · Cited by 18 · see citing works
Increased inflammation in BA21 brain tissue from African Americans with Alzheimer’s disease
Ferguson, S. A., Varma, V., Sloper, D. T., Panos, J., & Sarkar, S. (2019) · Metabolic Brain Disease · doi:10.1007/s11011-019-00512-2 · Cited by 18 · see citing works
Swann, P., Mirza-Davies, A., & O'Brien, J. T. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s385825 · Cited by 19 · see citing works
Carlson, M. C., Tschanz, J. T., Norton, M. C., Welsh-Bohmer, K. A., Martin, B. K., & Breitner, J. C. S. (2002) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200201000-00004 · Cited by 17 · see citing works
Yang, S., Shao, T., Yu, P., Cao, R., Zhang, M., Wen, K., Fan, M., & He, B. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.01.047 · Cited by 16 · see citing works
Serum BDNF, TNF- α and IL-1β levels in dementia patients
Yasutake, C. (2006) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-006-0702-2 · Cited by 16 · see citing works
Taipa, R. J. F., Sousa, A. L., Pires, M. M., & Sousa, N. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160121 · Cited by 14 · see citing works
The role of peripheral fatty acids as biomarkers for Alzheimer's disease and brain inflammation
Cisbani, G., & Bazinet, R. P. (2020) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2020.102205 · Cited by 14 · see citing works
- Authors
- Alvarez, X. A., Franco, A., Fernández-Novoa, L., & Cacabelos, R.
- Affiliations
- EuroEspes Biomedical Research Center (ES)
- ORCID
- Cacabelos, Ramón
- Venue
- Molecular and Chemical Neuropathology
- Published
- 1996-10
- Volume
- 29
- Issue
- 2-3
- Pages
- 237-252
- ISSN
- 1044-7393 (ISSN-L)
- OpenAlex
- W1978853688
- Cited by
- 139
- References
- 59
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 4 · 2023: 5 · 2022: 4 · 2021: 6 · 2020: 5 · 2019: 5 · 2018: 4 · 2017: 6 · 2016: 6 · 2015: 5 · 2014: 4 · 2013: 6 · 2012: 4
- FWCI
- 1.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Molecular and Chemical Neuropathology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, histamine, IL-1β, TNF-α, early-onset Alzheimer's disease, late-onset Alzheimer's disease, blood cytokines, cognitive impairment, depression, neuroinflammation, neuroprotection
- MeSH terms
- Aged, Alzheimer Disease, Cognition, Female, Histamine, Humans, Interleukin-1, Male, Middle Aged, Psychiatric Status Rating Scales, Reference Values, Tumor Necrosis Factor-alpha, Biomarkers, Age of Onset
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review